Wednesday, September 07, 2022
|
Sept. 7, 2022 (OTTAWA) – In response to an ongoing global shortage of immunoglobulins and risks to cross-border supply chains made further evident by the pandemic, Canadian Blood Services is announcing a blueprint for action to ensure patients in Canada continue to have long-term access to these lifesaving therapies.